SCHEMBL5037109

SCHEMBL5037109

CC(C)Oc1ccc(C(=O)NCc2ccc(CC3(C(=O)O)CCCO3)cc2)c(Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 4/20 0.41
MAPT P10636 3/20 0.41
GAA P10253 1/20 0.41
NR1H4 Q96RI1 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
TNKS O95271 2/20 0.38
TNKS2 Q9H2K2 2/20 0.38
THRB P10828 1/20 0.38
RXFP1 Q9HBX9 2/20 0.37
ALDH1A1 P00352 1/20 0.37
PPARG P37231 2/20 0.36
PPARA Q07869 2/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5034450 0.92 ALDH1A1 (0.39) TP53MAPTGAANPC1RAB9A
SCHEMBL5029881 0.88 PPARA (0.40) MAPTGAATNKSTNKS2THRB
SCHEMBL5037190 0.88 ALDH1A1 (0.39) TP53MAPTNPC1RAB9ATHRB
SCHEMBL5037171 0.87 PPARA (0.37) TP53MAPTGAANPC1RAB9A
SCHEMBL5032949 0.86 PDE4A (0.40)
SCHEMBL5031993 0.86 HPGD (0.42) MAPTGAATHRBPPARGPPARA
SCHEMBL5032927 0.81 ALDH1A1 (0.43) TP53MAPTNPC1RAB9ATNKS
SCHEMBL6888818 0.81 HTT (0.43) MAPTGAATNKSTNKS2THRB
SCHEMBL5029835 0.80 ALDH1A1 (0.42) TP53MAPTNPC1RAB9ATNKS
SCHEMBL5139950 0.79 ALDH1A1 (0.37) MAPTNPC1RAB9AALDH1A1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7371777-B2 Cyclic compound and PPAR agonist EISAI CO., LTD. (JP) 2008-05-13 US disclosed
US-7371777-B2 Cyclic compound and PPAR agonist EISAI CO., LTD. (JP) 2008-05-13 US disclosed
US-7371777-B2 Cyclic compound and PPAR agonist EISAI CO., LTD. (JP) 2008-05-13 US disclosed
US-20050014833-A1 Cyclic compound and ppar agonist EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-01-20 US disclosed
EP-1452521-A1 CYCLIC COMPOUND AND PPAR AGONIST Eisai Co., Ltd. (JP) 2004-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014833-A1 Cyclic compound and ppar agonist PPARA, PPARG, PPARD TP53 2471/4885MAPT 4663/4885GAA 4863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.